Parametrica Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Parametrica Management's BMY Position: Q2 2021 in Review
Parametrica Management sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 3,642 shares — an estimated $231K sold.
Parametrica Management first reported a position in BMY in Q4 2017 and held it in 2 quarters. The position peaked at $231K in Q1 2021. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.
- Parametrica Management reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
- Parametrica Management sold 3,642 Bristol-Myers Squibb shares in Q2 2021, an estimated $231K.
- Parametrica Management first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 2 quarters.
- Parametrica Management's Bristol-Myers Squibb position peaked at $231K in Q1 2021.
- 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.
Based on Parametrica Management's 13F filing for Q2 2021, filed 13 Aug 2021.